We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
(+7.6%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$43.6M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.6M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$36.1M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$35.4M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$41.5M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$36.1M |
| 3 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$27.3M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$22.9M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.43% |
| 2 | Financials | 4.62% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Healthcare | 3.87% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBR
2276
DELISTED
CyberArk
CYBR
| $412K | ﹤0.01% |
2,636
-244
| -8% | -$34.9K |
|
2277
Towne Bank
TOWN
$3.49B
| $412K | ﹤0.01% |
+17,725
| New | +$426K |
|
2278
City Holding Co
CHCO
$2.08B
| $411K | ﹤0.01% |
4,571
| – | – |
|
2279
Invesco Municipal Trust
VKQ
$545M
| $411K | ﹤0.01% |
43,534
+8,848
| +26% | +$84K |
|
2280
Atkore
ATKR
$3.17B
| $409K | ﹤0.01% |
2,626
+150
| +6% | +$19.7K |
|
2281
Tanger
SKT
$4.42B
| $409K | ﹤0.01% |
18,549
-280
| -1% | -$5.61K |
|
2282
First Citizens BancShares
FCNCA
$25.6B
| $408K | ﹤0.01% |
318
+14
| +5% | +$16.2K |
|
2283
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$965M
| $408K | ﹤0.01% |
15,572
-8,151
| -34% | -$215K |
|
2284
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$134M
| $408K | ﹤0.01% |
10,616
+296
| +3% | +$11.1K |
|
2285
Virtus SEIX Senior Loan ETF
SEIX
$253M
| $408K | ﹤0.01% |
17,311
-877
| -5% | -$20.6K |
|
2286
Innovator US Equity Ultra Buffer ETF March
UMAR
$196M
| $408K | ﹤0.01% |
13,558
+3,178
| +31% | +$92.7K |
|
2287
Bain Capital Specialty
BCSF
$821M
| $407K | ﹤0.01% |
+30,155
| New | +$373K |
|
2288
John B. Sanfilippo & Son
JBSS
$989M
| $407K | ﹤0.01% |
3,472
+63
| +2% | +$7.06K |
|
2289
OneAscent Emerging Markets ETF
OAEM
$131M
| $407K | ﹤0.01% |
14,135
+1,125
| +9% | +$31.8K |
|
|
XHR
2290
Xenia Hotels & Resorts
XHR
$1.73B
| $407K | ﹤0.01% |
33,053
+308
| +0.9% | +$3.84K |
|
2291
Nicholas Fixed Income Alternative ETF
FIAX
$129M
| $405K | ﹤0.01% |
+20,276
| New | +$406K |
|
2292
Elastic
ESTC
$8.94B
| $404K | ﹤0.01% |
6,304
-5
| -0.1% | -$313 |
|
|
SLCA
2293
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $404K | ﹤0.01% |
33,289
-2,104
| -6% | -$26K |
|
2294
Crane Co
CR
$12.9B
| $403K | ﹤0.01% |
+4,524
| New | +$349K |
|
2295
Goldman Sachs BDC
GSBD
$1.08B
| $403K | ﹤0.01% |
29,060
+10,235
| +54% | +$139K |
|
2296
McEwen Inc
MUX
$1.18B
| $403K | ﹤0.01% |
56,097
+14,381
| +34% | +$116K |
|
2297
Owens Corning
OC
$12.3B
| $403K | ﹤0.01% |
3,090
-726
| -19% | -$79.6K |
|
2298
Patrick Industries
PATK
$2.79B
| $402K | ﹤0.01% |
7,541
-669
| -8% | -$31.5K |
|
2299
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.51B
| $402K | ﹤0.01% |
16,107
-4,122
| -20% | -$100K |
|
|
NGD
2300
DELISTED
New Gold Inc
NGD
| $401K | ﹤0.01% |
371,597
+33,765
| +10% | +$41.8K |
|
Similar funds
LP
HF
RIM
Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
- Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
- Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
- Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
- Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
- Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.